about
LPS promotes a monocyte phenotype permissive for human cytomegalovirus immediate-early gene expression upon infection but not reactivation from latencyFunctional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells.Human cytomegalovirus and immunopathology.Report from the second cytomegalovirus and immunosenescence workshop.Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.CMV and Immunosenescence: from basics to clinics.Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells.The Expression of Human Cytomegalovirus MicroRNA MiR-UL148D during Latent Infection in Primary Myeloid Cells Inhibits Activin A-triggered Secretion of IL-6A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoirModulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells.Human cytomegalovirus immunity and immune evasion.How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future.Human cytomegalovirus miR-UL112-1 promotes the down-regulation of viral immediate early-gene expression during latency to prevent T-cell recognition of latently infected cells.HCMV activation of ERK-MAPK drives a multi-factorial response promoting the survival of infected myeloid progenitors.The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivoIntracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus.The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells.Regulation of NKG2D ligand gene expression.Human Cytomegalovirus (HCMV)-Specific CD4+ T Cells Are Polyfunctional and Can Respond to HCMV-Infected Dendritic Cells In Vitro.Corrigendum: The Expression of Human Cytomegalovirus MicroRNA MiR-UL148D during Latent Infection in Primary Myeloid Cells Inhibits Activin A-triggered Secretion of IL-6.Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice.Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells.Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responses.Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area.In vitro homotypic and heterotypic interference by defective interfering particles of West Nile virus.Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 Secretion during latent infection through changes in the cellular microRNA hsa-miR-92a.Human Cytomegalovirus Delays Neutrophil Apoptosis and Stimulates the Release of a Prosurvival Secretome.Immunosenescence and Cytomegalovirus: where do we stand after a decade?NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142.Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis.Immunogenicity of experimental live attenuated Japanese encephalitis vaccine viruses and comparison with wild-type strains using monoclonal and polyclonal antibodies.Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives.
P50
Q33678265-4AD0EB53-CCA3-4674-8EF8-21A23AA80016Q33810971-292F71B6-CF37-4AB1-9C89-5B5B1CCE16B5Q34262249-C91EA6CE-3CC1-46AE-B456-8BF45A7A6E0EQ35018043-068A9FC2-1B62-4985-ABD7-669177DB5FCEQ35034720-95B0F2DF-FEAE-4A7C-B215-4666E78E15BEQ35568719-66DE676A-9F70-4C1A-8791-D05C3E5D363BQ36171970-FE785EA7-13EA-4E82-9B13-3D1739A6D9CEQ36302615-A882D56E-09A8-4743-AC9E-8BAF713456CEQ36446460-46706133-D05B-4FCB-BE80-C959BD7DEDD8Q36649207-62BCC194-EB8C-4A84-BF1D-8AC20EBC1DF5Q36736566-527BCCE2-C0C9-41C2-9FD3-0C0BCC8A5516Q36810228-4289E1F3-2845-4160-97C2-6A1A415E6BB3Q37153807-295BAB48-B3CC-4E64-B666-A3F7C03AAC5DQ37663180-A1B04AAB-26B1-425B-944F-93DFBFE0431AQ37729495-866F8EA0-613A-4712-8F5A-14B81368A4B2Q37807749-A41086EF-4185-4703-A0B9-1950B4F48F9EQ38432092-ADFFE4B8-8503-4B9C-BFF1-A716792B90F2Q38758389-75B769C0-ACE6-4CFF-BA2B-E2AFF8AFCC13Q38793369-94E2AA44-86A0-4C38-B4C1-39317B16A90FQ39551804-ED9D2510-178D-4BD0-A618-EB7F68466942Q39696002-584002F7-0B77-40C9-8ABF-84F519D1D19DQ39876792-49543EFE-FFED-41B4-BD94-5B4677BBFD33Q40128250-B4D1B0ED-81BC-4E6E-BBAB-01B345E902FAQ40280290-C7053631-CF6A-465E-A724-66AD37C8E967Q40385338-5AE7057B-4FF0-4E8C-9AB4-0F434CADE4EFQ40528250-51CB59C1-97E3-4BBF-962E-D1BAFC39452DQ40733565-9550063F-636B-4C8A-9E32-C42A00E37647Q40756044-05D2EA92-DA34-46F3-ACD3-3B8A91BE4654Q40950550-8C6467A6-6801-4B13-8363-3A2559DE3877Q41277090-E4664B6D-14A6-46D6-93AA-AD7B38AC8D95Q41584034-61504DA9-2AE2-4A39-960E-85D778601718Q41648083-3D4D6955-7AE9-456E-AB06-38F35279FC71Q41657407-77746D56-12E1-4A2A-B26C-F7A052C9139BQ41727204-78F9F4DB-B303-45C4-BF96-C3C5DE13F259Q41921179-33245EF4-672C-4379-83A5-444D60796B2CQ41949218-3779733D-FBA4-420A-8A2C-1934F8CD7C13Q41951464-9F78BC73-4F95-422E-B1CE-1A7EAD427DD7Q42673828-1FEF2318-EDF2-4C1A-8E49-5AF1A02C7200Q42981257-C31F293E-3423-4791-BB2F-480E7687553EQ43048987-9D77D046-55FA-470A-9D89-16B378E1C37A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mark R Wills
@ast
Mark R Wills
@en
Mark R Wills
@es
Mark R Wills
@nl
Mark R Wills
@sl
type
label
Mark R Wills
@ast
Mark R Wills
@en
Mark R Wills
@es
Mark R Wills
@nl
Mark R Wills
@sl
prefLabel
Mark R Wills
@ast
Mark R Wills
@en
Mark R Wills
@es
Mark R Wills
@nl
Mark R Wills
@sl
P106
P21
P2798
P31
P496
0000-0001-8548-5729